Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.003 |